The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Anticoagulants for acute ischaemic stroke
Open accessAbstract
BACKGROUND: Most ischaemic strokes are caused by blood clots blocking an artery in the brain. Clot prevention with anticoagulants might improve outcome if bleeding risks were low. This is an update of a Cochrane review first published in 1995, and previously updated in 2004. OBJECTIVES: To assess the effect of anticoagulant therapy versus control in the early treatment (less than 14 days) of patients with acute ischaemic stroke. SEARCH STRATEGY: We searched the Cochrane Stroke Group Trials Register (last searched 2 October 2007), and two Internet clinical trials registries for relevant ongoing studies (last searched October 2007). SELECTION CRITERIA: Randomised trials comparing early anticoagulant therapy (started within two weeks of stroke onset) with control in patients with acute presumed or confirmed ischaemic stroke. DATA COLLECTION AND ANALYSIS: Two review authors independently selected trials for inclusion, assessed trial quality, and extracted the data. MAIN RESULTS: Twenty-four trials involving 23,748 participants were included. The quality of the trials varied considerably. The anticoagulants tested were standard unfractionated heparin, low-molecular-weight heparins, heparinoids, oral anticoagulants, and thrombin inhibitors. Based on 11 trials (22,776 participants) there was no evidence that anticoagulant therapy reduced the odds of death from all causes (odds ratio (OR) 1.05; 95% confidence interval (CI) 0.98 to 1.12) at the end of follow up. Similarly, based on eight trials (22,125 participants), there was no evidence that anticoagulants reduced the odds of being dead or dependent at the end of follow up (OR 0.99; 95% CI 0.93 to 1.04). Although anticoagulant therapy was associated with fewer recurrent ischaemic strokes (OR 0.76; 95% CI 0.65 to 0.88), it was also associated with an increase in symptomatic intracranial haemorrhages (OR 2.55; 95% CI 1.95 to 3.33). Similarly, anticoagulants reduced the frequency of pulmonary emboli (OR 0.60; 95% CI 0.44 to 0.81), but this benefit was offset by an increase in extracranial haemorrhages (OR 2.99; 95% CI 2.24 to 3.99). AUTHORS' CONCLUSIONS: Since the last version of the review, neither of the two new relevant studies have provided additional information to change the conclusions. In patients with acute ischaemic stroke, immediate anticoagulant therapy is not associated with net short or long-term benefit. Treatment with anticoagulants reduced recurrent stroke, deep vein thrombosis and pulmonary embolism, but increased bleeding risk. The data do not support the routine use of any the currently available anticoagulants in acute ischaemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314
Bamford, J., Sandercock, P., Dennis, M., Burn, J., & Warlow, C. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.1.16 · Cited by 814
Self-citationProceedings of the Royal Society of Medicine
(1942) · The Indian Journal of Pediatrics · doi:10.1007/bf02816934 · Cited by 799
Hemorrhagic and Ischemic Strokes Compared: Stroke Severity, Mortality, and Risk Factors
Andersen, K. K., Olsen, T. S., Dehlendorff, C., & Kammersgaard, L. P. (2009) · Stroke · doi:10.1161/strokeaha.108.540112 · Cited by 552
Complications After Acute Stroke
Davenport, R. J., Dennis, M. S., Wellwood, I., & Warlow, C. P. (1996) · Stroke · doi:10.1161/01.str.27.3.415 · Cited by 543
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment Investigators (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.279.16.1265 · Cited by 530
Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke
Kay, R., Wong, K. S., Yu, Y. L., Chan, Y. W., Tsoi, T. H., Ahuja, A. T., chan, F. L., Fong, K. Y., Law, C. B., Wong, A., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332402 · Cited by 474
Letter: The consultants' contract.
Plumley, P. F. (1974) · PubMed · Cited by 460
Randomisation to protect against selection bias in healthcare trials
Odgaard-Jensen, J., Vist, G. E., Timmer, A., Kunz, R., Akl, E. A., Schünemann, H., Briel, M., Nordmann, A. J., Pregno, S., & Oxman, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000012.pub3 · Cited by 439
Stroke epidemiology in the developing world
Feigin, V. L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66755-4 · Cited by 413
Sherman, D. G., Albers, G. W., Bladin, C., Fieschi, C., Gabbai, A. A., Kase, C. S., O'Riordan, W., & Pineo, G. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60633-3 · Cited by 326
Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.
(1983) · Stroke · doi:10.1161/01.str.14.5.668 · Cited by 303
Saxena, R., Lewis, S., Berge, E., Sandercock, P. A. G., Koudstaal, P. J., & for the International Stroke Trial Collaborative Group (2001) · Stroke · doi:10.1161/hs1001.097093 · Cited by 290
Self-citationAntithrombotic drugs for carotid artery dissection
Lyrer, P., & Engelter, S. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000255 · Cited by 275
Anticoagulation for cerebral sinus thrombosis
Stam, J., de Bruijn, S. F., & deVeber, G. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002005 · Cited by 242
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., del Zoppo, G. J., Yamaguchi, T., & Berge, E. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213 · Cited by 237
Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.
Sandercock, P. A., van den Belt, A. G., Lindley, R. I., & Slattery, J. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.1.17 · Cited by 206
Self-citationDUKE, R. J., BLOCH, R. F., ALEXANDER, G., TURPIE, G., TREBILCOCK, R., & BAYER, N. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-825 · Cited by 203
Turpie, A. G., Hirsh, J., Jay, R., Andrew, M., Hull, R., Levine, M., Carter, C., Powers, P., Magnani, H., & Gent, M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90173-5 · Cited by 200
Dahan, R., Houlbert, D., Caulin, C., Cuzin, E., Viltart, C., Woler, M., & Segrestaa, J. M. (1986) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000215286 · Cited by 199
LOW-DOSE HEPARIN AS A PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKE
Mccarthy, S. T., Robertson, D., Turner, J. J., Hawkey, C. J., & Macey, D. J. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90728-0 · Cited by 199
Anticoagulation for cerebral venous sinus thrombosis
Coutinho, J., de Bruijn, S. F., deVeber, G., & Stam, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002005.pub2 · Cited by 197
Lederle, F. A., Zylla, D., MacDonald, R., & Wilt, T. J. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-9-201111010-00008 · Cited by 167
Anticoagulation for Cerebral Sinus Thrombosis
Stam, J., de Bruijn, S., & deVeber, G. (2003) · Stroke · doi:10.1161/01.str.0000062344.87396.72 · Cited by 166
MCCARTHY, S. T., & TURNER, J. (1986) · Age and Ageing · doi:10.1093/ageing/15.2.84 · Cited by 160
Warlow, C., van Gijn, J., Dennis, M. S., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P. A., Rinkel, G. J. E., Langhorne, P., Sudlow, C. L. M., et al. (2008) · Wiley eBooks · doi:10.1002/9780470696361 · Cited by 139
Self-citationWhiteley, W. N., Adams, H. P., Bath, P. M., Berge, E., Sandset, P. M., Dennis, M. S., Murray, G. D., Wong, K. S., & Sandercock, P. A. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70079-6 · Cited by 137
Self-citationSandercock, P. A., & Leong, T. S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000119.pub4 · Cited by 135
Self-citationCamerlingo, M., Salvi, P., Belloni, G., Gamba, T., Cesana, B. M., & Mamoli, A. (2005) · Stroke · doi:10.1161/01.str.0000185730.50480.e7 · Cited by 120
Prins, M. H., Gelsema, R. G., Sing, A. K., van Heerde, L. R., & den Ottolander, G. J. H. (2009) · Haemostasis · doi:10.1159/000215979 · Cited by 111
Statistics Notes: Interaction 1: heterogeneity of effects
Altman, D. G., & Matthews, J. N. S. (1996) · BMJ · doi:10.1136/bmj.313.7055.486 · Cited by 107
Sandset, P. M., Dahl, T., Stiris, M., Rostad, B., Scheel, B., & Abildgaard, U. (1990) · PubMed · Cited by 105
Anticoagulants for acute ischaemic stroke
Gubitz, G. J., Sandercock, P. A., & Counsell, C. E. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000024.pub2 · Cited by 101
Self-citationEffect of the Thrombin Inhibitor Argatroban in Acute Cerebral Thrombosis
Kobayashi, S., & Tazaki, Y. (1997) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-996131 · Cited by 94
Interaction Between Warfarin and Panax ginseng in Ischemic Stroke Patients
Lee, S., Ahn, Y.-M., Ahn, S.-Y., Doo, H.-K., & Lee, B.-C. (2008) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2007.0799 · Cited by 91
Deep vein thrombosis: Prevention in stroke patients during rehabilitation
Pambianco, G., Orchard, T. J., & Landau, P. (1995) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(95)80657-1 · Cited by 81
Sequential computerized tomographic appearance of strokes.
Hakim, A. M., Ryder-Cooke, A., & Melanson, D. (1983) · Stroke · doi:10.1161/01.str.14.6.893 · Cited by 80
Fibrinogen depleting agents for acute ischaemic stroke
Hao, Z., Liu, M., Counsell, C. E., Wardlaw, J. M., Lin, S., & Zhao, X. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000091.pub2 · Cited by 74
Self-citationUse of Intravenous Heparin by North American Neurologists
Al-Sadat, A., Sunbulli, M., & Chaturvedi, S. (2002) · Stroke · doi:10.1161/01.str.0000018081.33541.e3 · Cited by 58
Élias, A., Milandre, L., Lagrange, G., Aillaud, M. F., Alonzo, B., Toulemonde, F., Juhan-Vague, I., Khalil, R., Bayrou, B., & Serradimigni, A. (1990) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)80622-8 · Cited by 41
(1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.4.371 · Cited by 25
A Cooperative Study of Cerebrovascular Disease
McDevitt, E., Groch, S. N., & WRIGHT, I. S. (1959) · Circulation · doi:10.1161/01.cir.20.2.215 · Cited by 19
Are very large trials of promising treatments for acute stroke feasible
Lindley, R. I. (1993) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 6
Yang, F., Lei, H., Jiang, W., Jiang, W., Han, J., & Zhao, G. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0228-8 · Cited by 5
Research works printed but not linked: 45
- LaMonte, 2004, Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1), Stroke, 35, 1677, 10.1161/01.STR.0000131549.20581.ba · doi:10.1161/01.str.0000131549.20581.ba
- Cazzato, 1989, Mesoglycan in the treatment of acute cerebral infarction, Rivista di Neurologia, 59, 121
- Chaudhry, 2002, Low molecular weight heparin In acute ischemic stroke, The Antiseptic, 99, 31
- Duke, 1980, Clinical trial of low-dose heparin for the prevention of stroke progression, Circulation, Suppl III, 21
- Duke, 1983, Clinical trial of low-dose subcutaneous heparin for the prevention of stroke progression: natural history of acute partial stroke and stroke-in-evolution, 399
- Duke, 1987, Heparin in acute partial stable stroke, Annals of Internal Medicine, 106, 782
- Easton, 1987, Heparin in acute partial stable stroke, Annals of Internal Medicine, 106, 781, 10.7326/0003-4819-106-5-781 · doi:10.7326/0003-4819-106-5-781
- Loeliger, 1987, Heparin in acute partial stable stroke, Annals of Internal Medicine, 106, 781, 10.7326/0003-4819-106-5-781 · doi:10.7326/0003-4819-106-5-781
- Kay, 1994, Fraxiparin in stroke study, Stroke, 25, 253
- Hommel, 1998, Fraxiparine in Ischaemic Stroke Study (FISS bis), Cerebrovascular Diseases, 8 Suppl 4, 19
- Kwiecinski, 1995, A randomized trial of fraxiparine in acute ischaemic stroke, Cerebrovascular Diseases, 5, 234
- Marshall, 1960, Anticoagulant therapy in acute cerebrovascular accidents: a controlled trial, Lancet, 1, 995, 10.1016/S0140-6736(60)90885-0 · doi:10.1016/s0140-6736(60)90885-0
- Baker, 1962, Anticoagulant therapy in cerebral infarction. Report on co-operative study, Neurology, 12, 823, 10.1212/WNL.12.12.823 · doi:10.1212/wnl.12.12.823
- Miller Fisher, 1961, Anticoagulant therapy in cerebral thrombosis and cerebral embolism. A national cooperative study, interim report, Neurology, 11, 119, 10.1212/WNL.11.4_Part_2.119 · doi:10.1212/wnl.11.4_part_2.119
- Desmukh, 1991, Deep vein thrombosis in rehabilitating stroke patients. Incidence, risk factors and prophylaxis, American Journal of Physical Medicine and Rehabilitation, 70, 313, 10.1097/00002060-199112000-00006 · doi:10.1097/00002060-199112000-00006
- Pince, 1981, Thromboses veineuses des membres inferieurs et embolies pulmonaires au cours des accidents vasculaires cerebraux. A propos d'un essai comparitif de traitement preventif (These pour le doctorat d'etat en medecine)
- Prins, 1987, Deep venous thrombosis prophylaxis with a LMW heparin (KABI 2165) in stroke patients, Thrombosis and Haemostasis, 58, 117
- Sandset, 1987, Venous thromboembolic complications in acute thrombotic stroke. Progress report from a randomized trial, Acta Neurologia Scandinavica, 76, 392
- Tazaki, 1986, Therapeutic effect of thrombin inhibitor MD-805 in acute phase of cerebral thrombosis - Phase II double-blinded clinical trial (English translation), Rinsho to Kenkyu (Japanese Journal of Clinical and Experimental Medicine), 63, 3047
- Tazaki, 1992, Clinical usefulness of thrombin inhibitor MD-805 in acute phase of cerebral thrombosis - double blinded comparative study using placebo as a control (English translation), Igaku no Ayumi (Journal of Clinical and Experimental Medicine), 161, 887
- Adams, 1994, Trial of Org 10172 in Acute Stroke Treatment (TOAST), Stroke, 25, 545
- Turpie, 1988, Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke, Acta Chirurgica Scandinavica Supplementum, 543, 85
- Turpie, 1987, A double-blind randomized trial of Org 10172 low molecular weight heparinoid in the prevention of deep venous thrombosis in patients with thrombotic stroke, Thrombosis and Haemostasis, 58, 123
- Bradshaw, 1975, Trial of long-term anticoagulant therapy in the treatment of small stroke associated with a normal carotid angiogram, Journal of Neurology Neurosurgery and Psychiatry, 38, 642, 10.1136/jnnp.38.7.642 · doi:10.1136/jnnp.38.7.642
- Carter, 1961, Anticoagulant treatment in progressing stroke, BMJ, II, 70, 10.1136/bmj.2.5244.70 · doi:10.1136/bmj.2.5244.70
- Carter, 1961, Use of anticoagulants in patients with progressive cerebral infarction, Neurology, 11, 601, 10.1212/WNL.11.7.601 · doi:10.1212/wnl.11.7.601
- Czechanowski, 1981, Prevention of venous thrombosis in recent ischaemic cerebrovascular accident: double-blind study with heparin-dihydroergotamine, Deutsche Medizinische Wochenschrift, 106, 1254, 10.1055/s-2008-1070492 · doi:10.1055/s-2008-1070492
- Dan, 2001, Improvement of outcome in patients with acute ischaemic stroke treated with fragmin, Haemostasis, 30 Suppl 2, 168
- Enger, 1965, Long term anticoagulant therapy in patients with cerebral infarction: a controlled clinical study, Acta Medica Scandinavica, 178 Suppl 438, 7
- Eriksson, 1983, Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit, Acta Neurologica Scandinavica, 68, 96, 10.1111/j.1600-0404.1983.tb04823.x · doi:10.1111/j.1600-0404.1983.tb04823.x
- Gelmers, 1980, Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic stroke, Acta Neurologica Scandinavica, 61, 313, 10.1111/j.1600-0404.1980.tb01498.x · doi:10.1111/j.1600-0404.1980.tb01498.x
- Kario, 1995, Thrombin inhibition in the acute phase of ischaemic stroke using argatroban, Blood Coagulation and Fibrinolysis, 6, 423, 10.1097/00001721-199507000-00008 · doi:10.1097/00001721-199507000-00008
- Lee, 1994, Therapeutic efficacy of urokinase and heparin in acute ischemic stroke, Stroke, 25, 268
- McCarthy S McWalter R Durkin CJ Hallawi AH Magnani HN Pearson J Org 10172 for the prophylaxis of deep venous thrombosis in the legs (A protocol to establish the efficacy and safety of once or twice daily subcutaneous Org 10172 injections versus placebo in three groups of 60 non-haemorrhagic stroke victims) Unpublished protocol
- Groch, 1961, A long-term study of cerebral vascular disease, Annals of Internal Medicine, 55, 358, 10.7326/0003-4819-55-3-358 · doi:10.7326/0003-4819-55-3-358
- McDowell, 1965, Treatment of the completed stroke with long-term anticoagulant: six and one-half years experience, 185
- McDowell, 1963, Anticoagulant therapy: five years' experience with the patient with an established cerebrovascular accident, Archives of Neurology, 8, 209, 10.1001/archneur.1963.00460020109009 · doi:10.1001/archneur.1963.00460020109009
- Shi, 2004, The clinical observation of low molecular weight heparin calcium in treating patients with acute cerebral infarction, Pharmaceutical Care and Research, 4, 258
- Tan, 1998, Nardoparin in treating cerebral embolism and thrombosis, Chinese Journal of New Drugs and Clinical Remedies, 17, 325
- Thygesen, 1964, Cerebral apoplexy: a clinical, radiological, electroencephalographic and pathological study with special reference to the prognosis of cerebral infarction and the result of long-term anticoagulant therapy, Danish Medical Bulletin, 11, 233
- Tsuchiya, 1989, Effects of urokinase and heparin on haemorrhagic infarction, recanalisation, recurrence - analysis of 111 cases with middle cerebral artery occlusion on a prospective controlled trial [author's translation], Japanese Journal of Stroke, 11, 500, 10.3995/jstroke.11.500 · doi:10.3995/jstroke.11.500
- Tsuchiya, 1990, A study on clinical effects of urokinase and heparin for acute lacunar infarcts in a prospective controlled trial, Japanese Journal of Stroke, 11, 177, 10.3995/jstroke.12.177 · doi:10.3995/jstroke.12.177
- Baker, 1961, An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease. Report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section, Neurology, 11, 132, 10.1212/WNL.11.4_Part_2.132 · doi:10.1212/wnl.11.4_part_2.132
- Zhang, 2005, Clinical study of low molecular weight heparin calcium and aspirin therapy on acute cerebral infarction, Clinical Pharmacology, 40, 634
- Bland, 2003, Tests for interaction, BMJ, 326, 219
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2018) · Stroke · doi:10.1161/str.0000000000000158 · Cited by 5,446
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Adams, H. P., Adams, R. J., Brott, T., del Zoppo, G. J., Furlan, A., Goldstein, L. B., Grubb, R. L., Higashida, R., Kidwell, C., Kwiatkowski, T. G., et al. (2003) · Stroke · doi:10.1161/01.str.0000064841.47697.22 · Cited by 1,245
Metadata
- Authors
- Sandercock, P. A., Counsell, C., & Kamal, A. K.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2008-10-08
- Issue
- 3
- Pages
- CD000024-CD000024
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W2121822256
- Cited by
- 346
- References
- 64
- Type
- reference entry
- Language
- en
- Update notices
- new_version (2015-03-12)
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.